Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Plos One|June 19, 2019
Altered ocular parameters from circadian clock gene disruptionsRichard A Stone, Alice M McGlinn, Ranjay Chakraborty, et al.Journal of Neurotrauma|August 6, 2021
A Tropomycin-Related Kinase B Receptor Activator for the Management of Ocular Blast-Induced Vision LossSusov Dhakal, Li He, Polina Lyuboslavsky, et al.Plos One|February 7, 2018
Daily visual stimulation in the critical period enhances multiple aspects of vision through BDNF-mediated pathways in the mouse retinaAmanda M Mui, Victoria Yang, Moe H Aung, et al.Frontiers in Cellular Neuroscience|February 27, 2023
Deletion of histone demethylase Lsd1 (Kdm1a) during retinal development leads to defects in retinal function and structureSalma Ferdous, Debresha A Shelton, Tatiana E Getz, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 26, 2010
Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylaseJason P Schroeder, Debra A Cooper, Jesse R Schank, et al.Frontiers in Neuroscience|April 10, 2023
Diabetic rats with high levels of endogenous dopamine do not show retinal vascular pathologyRachael S Allen, Cara T Khayat, Andrew J Feola, et al.Molecular Vision|November 11, 2016
IRBP deficiency permits precocious ocular development and myopiaShanu Markand, Natecia L Baskin, Ranjay Chakraborty, et al.Diabetes|February 14, 2020
Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic RetinopathyCara T Motz, Kyle C Chesler, Rachael S Allen, et al.Nature Structural & Molecular Biology|July 4, 2017
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's diseaseZhentao Zhang, Seong Su Kang, Xia Liu, et al.Nature Cell Biology|April 3, 2019
An opsin 5-dopamine pathway mediates light-dependent vascular development in the eyeMinh-Thanh T Nguyen, Shruti Vemaraju, Gowri Nayak, et al.Pageof 12